Arthur McGivern, a partner in Goodwin Procter’sTechnology & Life Sciences Group, discusses how the number of U.S. companies debuting public stock continues to slow in recent years, as uncertainty over Brexit and other world events make investors nervous.
Read the full Bloomberg BNA article here.
Related Content
- Big Molecule WatchMay 1, 2024
PTAB Issues Final Written Decisions Finding Claims of Recombinant Lentiviral Vector Patents Valid
- Life Sciences PerspectivesApril 30, 2024
FDA Issues Final Rule on Regulation of Laboratory Developed Tests
- Big Molecule WatchApril 30, 2024
Biosimilar Approval Updates in Europe and China
- Big Molecule WatchApril 29, 2024
GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech for Infringing mRNA Vaccine Patents
- Big Molecule WatchApril 29, 2024
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR
- Big Molecule WatchApril 26, 2024
Alvotech Announces Positive Topline Results From Confirmatory Clinical Study for its Proposed Golimumab Biosimilar
- AlertApril 25, 2024
FTC Issues Final Rule Prohibiting Most Post-Employment Non-Compete Agreements
- Life Sciences PerspectivesApril 23, 2024
The European Parliament Adopts Position on the European Commission’s Proposal for the First Major Overhaul of the EU Medicines Regulatory Framework in 20 Years
- Press ReleaseMay 2, 2024
Mariana Oncology To Be Acquired by Novartis For $1 Billion Upfront, And Up To $750 Million in Milestones
- Press ReleaseApril 29, 2024
Deciphera Pharmaceuticals To Be Acquired By ONO Pharmaceutical For $2.4 Billion
- Press Release29 April 2024
Amid Continued Growth in the United Kingdom, Goodwin Relocates London Office to Iconic Paternoster Square
- Press ReleaseApril 23, 2024
Allurion Technologies Completes $48 Million Convertible Senior Secured Note Financing with RTW Investments
- Press ReleaseApril 22, 2024
Sound Bioventures joins £19 Million Financing of Theolytics
- In the PressApril 22, 2024
PowerUp 4 - Omer Tene (Spotify)
- Awards and RankingsApril 18, 2024
Goodwin is Number One in the Q1 2024 League Table Rankings
- Press ReleaseApril 18, 2024
Lumicell’s Novel Optical Imaging Agent Platform LUMISIGHT™ & Direct Visualization System for Detection of Residual Breast Cancer Receives FDA Approval